CEO Robert Parkinson

New York, May 25th (TradersHuddle.com) - Baxter International, Inc. (NYSE:BAX) closed the trading session at $52.25, near its 200 day moving average set at $54.45. Baxter's stock action is below this level, which makes the stock difficult to be bought, as ...  

Analyzing the price chart for Baxter International (NYSE:BAX) has revealed a potential bullish harami candle pattern. Today's real body is within yesterday's body and may imply that traders and investors believe that the recent move lower is exhausted.  

Baxter appealed an obviousness finding from a re-examination proceeding.  The CAFC noted Because the Board did not err in determining that those claims would have been obvious to one of ordinary skill in the art, we affirm.From the decision:  First, as recounted above, the Board expressly considered our decision in Fresenius. More fun- damentally, the PTO in reexamination proceedings and the court system in patent infringement actions “take...  

Baxter International Inc.’s more than $1 billion Covington, Ga., plant is a bet on the long-term growth of the company’s plasma-based specialty therapeutics business, company executives said in a conference call with analysts Thursday. “The announcement this morning is an expression that represents our confidence in the long-term global growth of the plasma protein business,” CEO Robert Parkinson told analysts. “Over half the world’s...  

PARIS--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX) today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis (PD) regimen favorably impacted metabolic measures important for ...  

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced the approval of ADVATE [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with hemophilia A (congenital factor VIII deficiency) in China by the State Food and Drug Administration (SFDA). It is estimated that more than 50,000 people in China...  

(RTTNews) - Baxter International Inc. (BAX: News ) said results from two large, international multicenter trials demonstrated that a low glucose peritoneal dialysis, or PD, regimen favorably impacted metabolic measures important for end-stage renal disease ...  

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today it has exercised its option and completed the purchase of SIGMA International General Medical Apparatus, LLC., a privately held company based in Medina, New York, by acquiring the remaining 60 percent of the company for a cash payment of approximately $90 million. In 2009, Baxter entered into an agreement with SIGMA...  

DEERFIELD, Ill. & SAN DIEGO--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX - News) and Halozyme Therapeutics, Inc. (NASDAQ:HALO - News) today announced that the U.S. Food and Drug Administration (FDA) is requesting additional information to complete its review of the HyQ Biologics License Application (BLA).Baxter and Halozyme will work closely together to develop studies to provide...  

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at Deutsche Bank Securities, Inc. 37th Annual Healthcare Conference on Wednesday, May 9, 2012, at 9:20 a.m. ET. The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through June 8, 2012. Baxter International Inc. develops, manufactures and markets...  

DEERFIELD, Ill. — Drug and medical device maker Baxter International Inc. said Thursday its profit grew 3 percent in the first quarter on better sales of hemophilia and immune disease treatments, anesthetics, and other products. Baxter said ...  

Inc. (Synovis) acquisition, which was completed during the quarter, and solid growth in select specialty plasma-based therapies and vaccines. Medical Products sales of more than $1.9 billion increased 3 percent (with foreign currency having no impact on ...  

NEW YORK (AVAFIN) -- Baxter International witnessed an unusual number of call and put contracts exchanging hands during the busy trading session versus the average 10-day contract volume . There were 0.8 call contracts traded for every put ...  

will soon be home to Baxter International Inc.’s Baxter International Inc. Latest from The Business Journals Follow this company (NYSE: BAX) new $1 billion plasma-based treatments manufacturing plant. The facility will create more than 1,500 ...  

Over at Georgia Report, Tom Crawford is reporting that the incentive package that bio-tech firm Baxter International received to build a manufacturing facility in east Georgia could exceed $126.5 million: That amount is about 62 percent higher ...